Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Rujescu

Showing results (241-250 of 480) with videos related to

Pageof 48
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 2, 2020
Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic studyChiara Fabbri, Siegfried Kasper, Joseph Zohar, et al.
Pharmacogenomics|November 19, 2013
Opening Pandora's box in the UK: a hypothetical pharmacogenetic test for clozapineBenjamin W J Spencer, Barbara Prainsack, Dan Rujescu, et al.
Archives of General Psychiatry|February 6, 2004
Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depressionThomas Frodl, Eva M Meisenzahl, Peter Zill, et al.
Pharmacogenetics and Genomics|October 2, 2009
Influence of 5-HT3 receptor subunit genes HTR3A, HTR3B, HTR3C, HTR3D and HTR3E on treatment response to antipsychotics in schizophreniaAnna Schuhmacher, Rainald Mössner, Boris B Quednow, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 12, 2025
Clinical predictors of treatment resistant depressionAlessandro Serretti, Siegfried Kasper, Lucie Bartova, et al.
BMC Psychiatry|October 12, 2023
Patient characteristics, validity of clinical diagnoses and Outcomes Associated with Suicidality in Inpatients with Symptoms of Depression (OASIS-D): design, procedures and outcomesViktor B Nöhles, Felix Bermpohl, Peter Falkai, et al.
Journal of Affective Disorders|October 24, 2024
Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issuesPaolo Olgiati, Siegfried Kasper, Joseph Zohar, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|March 27, 2019
Attitudes toward the right to autonomous decision-making in psychiatric genetic testing: Controversial and context-dependentJana Strohmaier, Stephanie H Witt, Josef Frank, et al.
Journal of Affective Disorders|March 23, 2023
Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorderLucie Bartova, Gernot Fugger, Markus Dold, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 7, 2005
Polymorphisms in the NMDA subunit 2B are not associated with alcohol dependence and alcohol withdrawal-induced seizures and delirium tremensAndre Tadic, Norbert Dahmen, Armin Szegedi, et al.
Pageof 48

Showing results (241-250 of 480) with videos related to

Sort By:
Pageof 48
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 2, 2020
Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic studyChiara Fabbri, Siegfried Kasper, Joseph Zohar, et al.
Pharmacogenomics|November 19, 2013
Opening Pandora's box in the UK: a hypothetical pharmacogenetic test for clozapineBenjamin W J Spencer, Barbara Prainsack, Dan Rujescu, et al.
Archives of General Psychiatry|February 6, 2004
Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depressionThomas Frodl, Eva M Meisenzahl, Peter Zill, et al.
Pharmacogenetics and Genomics|October 2, 2009
Influence of 5-HT3 receptor subunit genes HTR3A, HTR3B, HTR3C, HTR3D and HTR3E on treatment response to antipsychotics in schizophreniaAnna Schuhmacher, Rainald Mössner, Boris B Quednow, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 12, 2025
Clinical predictors of treatment resistant depressionAlessandro Serretti, Siegfried Kasper, Lucie Bartova, et al.
BMC Psychiatry|October 12, 2023
Patient characteristics, validity of clinical diagnoses and Outcomes Associated with Suicidality in Inpatients with Symptoms of Depression (OASIS-D): design, procedures and outcomesViktor B Nöhles, Felix Bermpohl, Peter Falkai, et al.
Journal of Affective Disorders|October 24, 2024
Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issuesPaolo Olgiati, Siegfried Kasper, Joseph Zohar, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|March 27, 2019
Attitudes toward the right to autonomous decision-making in psychiatric genetic testing: Controversial and context-dependentJana Strohmaier, Stephanie H Witt, Josef Frank, et al.
Journal of Affective Disorders|March 23, 2023
Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorderLucie Bartova, Gernot Fugger, Markus Dold, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 7, 2005
Polymorphisms in the NMDA subunit 2B are not associated with alcohol dependence and alcohol withdrawal-induced seizures and delirium tremensAndre Tadic, Norbert Dahmen, Armin Szegedi, et al.
Pageof 48